RIGHTS OF Sample Clauses

RIGHTS OF. ASSIGNEE Any assignee, transferee or sub-participant of a Bank shall (unless limited by the express terms of the assignment, transfer or sub-participation) take the full benefit of every provision of the Security Documents benefiting that Bank.

RIGHTS OF. Any rights of management which are not specifically mentioned in this Agreement and are not contrary t o its intention shall continue in full force and effect for the duration of this contract, always provided that in the exercise of the aforementioned management rights there shall be no discrimination.

RIGHTS OF. [Credit Enhancer] to Direct Trustee; Class B Certificateholder's Right of First Refusal. (a) The [Credit Enhancer], after giving written notice to the Trustee, shall have the right to direct the time, method and place at or by which the Trustee conducts any proceeding for any remedy available to the Trustee, or exercises any such trust or power conferred upon the Trustee. (b) If in the exercise of its rights, powers and remedies under Subsection (a) above, the [Credit Enhancer] directs the Trustee to liquidate Receivables with an aggregate Principal Balance exceeding [ ]% of the aggregate Principal Balance of all Receivables by selling such Receivables to one or more third parties in one or more substantially contemporaneous sales, the [Credit Enhancer] shall notify the Rating Agencies thereof and shall direct the Trustee, prior to contracting to sell any such Receivables to a third party, to notify any Holder of Class B Certificates evidencing in the aggregate more than [ ]% of the Class B Certificate Balance of its intent to sell such Receivables and of the amount of the highest bid the Trustee has received to purchase such Receivables (the "Strike Bid"). The Class B Certificateholders or their designee shall have [ten (10)] Business Days from the date of notification to submit a bid equal to or greater than the Strike Bid. If the Trustee has not received a bid from such Class B Certificateholders or their designee within such ten (10) Business Day period, the [Credit Enhancer] shall be entitled to direct the Trustee to consummate the purchase at the Strike Bid. If the Trustee receives a bid equal to or greater than the Strike Bid from the Class B Certificateholders or their designee within such ten (10) Business Day period the [Credit Enhancer] shall direct the Trustee to accept such bid of the Class B Certificateholders or their designee. (c) Notwithstanding anything to the contrary contained in subsections (a) or (b) above, the Trustee shall have the right to decline to follow any such direction of the [Credit Enhancer] if the Trustee, being advised by counsel, determines that the action so directed may not lawfully be taken, or if the Trustee in good faith shall, by a responsible officer of the Trustee, determine that the proceedings so directed would be illegal or involve it in personal liability or be unduly prejudicial to the rights of Certificateholders; provided, that nothing in this Agreement shall impair the right of the Trustee to take any ac...

RIGHTS OF. (Program administrator)

RIGHTS OF. Way polygon data layer a. Rights-of-Way polygon data layer developed from available existing client or DOT detailed rights-of-way documents for federal and state roads, and other areas ROW areas, provided to The Xxxxxxxxx Corporation at the beginning of the project; and uniform width rights-of-way centered on remaining road centerlines or USPLS section lines. Uniform width rights-of-way measurements (66 feet or otherwise) will be determined and identified by the client for The Xxxxxxxxx Corporation prior to the beginning of the project. b. Rights-of-Way will be annotated with dimensions as identified on available sources. c. Rights-of-Way will be attributed with ROW class (local, state, federal). d. “Rights-of-Way will be attributed with document ID, providing a link to the scanned ROW source document used for conversion. The link will be able to be accessed through the Report Interface software provided under this agreement.”

RIGHTS OF. ADMINISTRATIVE AGENT AND ITS AFFILIATES AS A BANK. With respect to any Loan made by Wachovia or an Affiliate of Wachovia, such Affiliate and Wachovia in their capacity as a Bank hereunder shall have the same rights and powers hereunder as any other Bank and may exercise the same as though it were not an Affiliate of Wachovia (or in Wachovia's case, acting as the Administrative Agent), and the term "Bank" or "Banks" shall, unless the context otherwise indicates, include such Affiliate of Wachovia or Wachovia in its individual capacity. Such Affiliate and Wachovia may (without having to account therefor to any Bank) accept deposits from, lend money to and generally engage in any kind of banking, trust or other business with the Borrower (and any of its Affiliates) as if they were not an Affiliate of the Administrative Agent or acting as the Administrative Agent, respectively; and such Affiliate and Wachovia may accept fees and other consideration from the Borrower (in addition to any agency fees and arrangement fees heretofore agreed to between the Borrower and Wachovia) for services in connection with this Agreement or any other Loan Document or otherwise without having to account for the same to the Banks.

RIGHTS OF. ADMINISTRATIVE AGENT AS HOLDER OF SENIOR INDEBTEDNEESS; INDEBTEDNESS; PRESERVATION OF ADMINISTRATIVE AGENT'S RIGHTS. The Administrative Agent in its individual capacity shall be entitled to all the rights set forth in this ARTICLE IX with respect to any Alderwoods--Subordinated Bridge Loan Agreement 46 Senior Indebtedness that may at any time be held by it, to the same extent as any other holder of Senior Indebtedness, and nothing in this Agreement shall deprive the Administrative Agent of any of its rights as such holder.

RIGHTS OF. Administrative Agent and its Affiliates as a Bank. With respect to any Loan made by Hibernia or an Affiliate of Hibernia such Affiliate and Hibernia in their capacity as a Bank hereunder shall have the same rights and powers hereunder as any other Bank and may exercise the same as though it were not an Affiliate of Hibernia (or in Hibernia's case, acting as the Administrative Agent) and the term "Bank" or "Banks" shall, unless the context otherwise indicates, include such Affiliate of Hibernia or Hibernia in its individual capacity. Such Affiliate and Hibernia may (without having to account therefor to any Bank) accept deposits from, lend money to and generally engage in any kind of banking, trust or other business with the Borrower (and any of its Affiliates) as if they were not an Affiliate of the Administrative Agent or the Administrative Agent, respectively, and such Affiliate and Hibernia may accept fees and other consideration from the Borrower (in addition to any agency fees and arrangement fees heretofore agreed to between the Borrower and Hibernia) for services in connection with this Agreement or any other Loan Document or otherwise without having to account for the same to the Banks.

RIGHTS OF. Designation by [***]. (a) Rights of [***]. [***] shall continue to have rights to develop, market and/or commercialize in the Territory outside the Field only a limited number of individual Compounds (and Products containing the same) which have been selected as [***] Selected Compounds in accordance with this Section 5.3.3 for [***] Programs. (b) [***]’s Designation of Reserve Compounds. [***] may designate a Compound as an [***] Reserve Compound at any time upon notice to Patent Counsel, provided at the time of such notice (i) as to any Compound that is identified, synthesized, discovered, designed or acquired after the Effective Date other than pursuant to an [***] Program, one year has elapsed since its Compound Registration Date; (ii) such Compound is not then a Selected Compound, a Non-Cancer Selected Compound or an Opt-out Non-Cancer Selected HDAC Inhibitor, and (iii) there are not then more than [***] [***] Reserve Compounds for [***]. In the event [***] then-currently has [***] [***] Reserve Compounds, then [***] shall not have the right to include any additional Compound(s) as [***] Reserve Compounds, until [***] has removed an equal number of Compounds from its list of [***] Reserve Compounds, chosen at [***]’s sole discretion. For the foregoing purpose, it is understood and agreed that [***] shall have the right to remove any Compound from its list of [***] Reserve Compounds at any time upon written notice to Patent Counsel. In the event a Compound is so removed from the list of [***] Reserve Compounds, then such Compound shall thereafter cease to be an [***] Selected Compound (unless re-designated in accordance with this Section 5.3.3(b)), and [***] shall have no further rights to develop, market and/or commercialize such Compounds in the Territory as part of [***] Program outside the Field. (c) Elevation of [***] Reserve Compounds. Upon commencement of (i) Phase I clinical studies by or under authority of [***] with respect to a Compound(s) outside the Field, and provided that (ii) such Compound(s) are [***] Reserve Compound(s) at the time of the [***]’s notice to Patent Counsel of such commencement under this Section 5.3.3(c) such Compound shall cease to be an [***] Reserve Compound but shall remain an [***] Selected Compound hereunder (i.e., such Compound will no longer count against the maximum number of [***] [***] Reserve Compounds for [***]). (d) Development Candidate Selection by [***]. [***] may designate one (1) Compound at any time ...

RIGHTS OF. In the event MG obtains Pharmion’s consent not to undertake, or to abandon Prosecution of the Licensed Patents described in Section 17.4.5(a) above, and not otherwise, then MG may be required to notify one or more of its [***] prior to any required action (or such shorter period as is reasonably practicable for non-extendable deadlines), but only with respect to any such Licensed Patents that are relevant to the field of use of such [***] and to the geographical territory set forth in the applicable [***] Agreement(s). In such event, a [***] may have the right, but not the obligation, to control the Prosecution of such Licensed Patents, and MG may cooperate with such [***] with respect thereto, provided that such [***] shall keep MG reasonably informed of such Prosecution as requested by MG. In the event a [***] takes over Prosecution of such a Licensed Patents in accordance with this Section 17.4.6, it may obtain the right to complete discretion with respect to any decisions regarding such Prosecution, and shall not owe any duties, express or implied, to MG with respect to such decisions. Notwithstanding the foregoing, in the event such [***] does not elect to undertake or continue the Prosecution of any item of the Licensed Patents described herein within thirty (30) days after MG has notified it of its rights hereunder, then MG shall promptly notify Pharmion in writing, and Pharmion shall have the right, but not the obligation, to assume control of the Prosecution of such Licensed Patents.